116 related articles for article (PubMed ID: 23451715)
1. Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice.
Jackman RP; Muench MO; Heitman JW; Inglis HC; Law JP; Marschner S; Goodrich RP; Norris PJ
Transfusion; 2013 Nov; 53(11):2697-709. PubMed ID: 23451715
[TBL] [Abstract][Full Text] [Related]
2. Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets.
Muench MO; Heitman JW; Inglis H; Fomin ME; Marschner S; Goodrich RP; Norris PJ; Jackman RP
Transfusion; 2016 Jun; 56(6):1419-29. PubMed ID: 27028210
[TBL] [Abstract][Full Text] [Related]
3. Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood.
Jackman RP; Muench MO; Inglis H; Heitman JW; Marschner S; Goodrich RP; Norris PJ
Transfusion; 2017 Feb; 57(2):337-348. PubMed ID: 27859333
[TBL] [Abstract][Full Text] [Related]
4. Pathogen reduction with riboflavin and ultraviolet light induces a quasi-apoptotic state in blood leukocytes.
Tran JQ; Muench MO; Heitman JW; Jackman RP
Transfusion; 2019 Nov; 59(11):3501-3510. PubMed ID: 31599981
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic major histocompatibility complex antigens are necessary and sufficient for partial tolerance induced by transfusion of pathogen reduced platelets in mice.
Tran JQ; Muench MO; Heitman JW; Jackman RP
Vox Sang; 2019 Apr; 114(3):207-215. PubMed ID: 30734299
[TBL] [Abstract][Full Text] [Related]
6. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants.
Asano H; Lee CY; Fox-Talbot K; Koh CM; Erdinc MM; Marschner S; Keil S; Goodrich RP; Baldwin WM
Transplantation; 2007 Nov; 84(9):1174-82. PubMed ID: 17998874
[TBL] [Abstract][Full Text] [Related]
7. Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells.
Tormey CA; Santhanakrishnan M; Smith NH; Liu J; Marschner S; Goodrich RP; Hendrickson JE
Transfusion; 2016 Apr; 56(4):863-72. PubMed ID: 26643781
[TBL] [Abstract][Full Text] [Related]
8. Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products.
Pohler P; Müller M; Winkler C; Schaudien D; Sewald K; Müller TH; Seltsam A
Transfusion; 2015 Feb; 55(2):337-47. PubMed ID: 25134439
[TBL] [Abstract][Full Text] [Related]
9. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
[TBL] [Abstract][Full Text] [Related]
10. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
Fast LD; Nevola M; Tavares J; Reddy HL; Goodrich RP; Marschner S
Transfusion; 2013 Feb; 53(2):373-81. PubMed ID: 22612327
[TBL] [Abstract][Full Text] [Related]
11. A small allelic variant in donor class I MHC is sufficient to induce alloantibodies following transfusion of standard or pathogen-reduced platelets in mice.
Jackman RP; Heitman JW; Muench MO
Vox Sang; 2020 Jul; 115(5):367-376. PubMed ID: 32201962
[TBL] [Abstract][Full Text] [Related]
12. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
Ambruso DR; Thurman G; Marschner S; Goodrich RP
Transfusion; 2009 Dec; 49(12):2631-6. PubMed ID: 19694996
[TBL] [Abstract][Full Text] [Related]
13. Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.
Jackman RP; Heitman JW; Marschner S; Goodrich RP; Norris PJ
Transfusion; 2009 Dec; 49(12):2686-99. PubMed ID: 19682337
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet B light-exposed human platelets mediate acute lung injury in a two-event mouse model of transfusion.
Gelderman MP; Chi X; Zhi L; Vostal JG
Transfusion; 2011 Nov; 51(11):2343-57. PubMed ID: 21492179
[TBL] [Abstract][Full Text] [Related]
15. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity.
Semple JW; Speck ER; Cosgrave D; Lazarus AH; Blanchette VS; Freedman J
Blood; 1999 Jan; 93(2):713-20. PubMed ID: 9885234
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions.
Waterman HR; Kapp LM; Munday A; Odem-Davis K; Zimring JC
Transfusion; 2016 Jan; 56(1):91-100. PubMed ID: 26400622
[TBL] [Abstract][Full Text] [Related]
17. White blood cell inactivation after treatment with riboflavin and ultraviolet light.
Marschner S; Fast LD; Baldwin WM; Slichter SJ; Goodrich RP
Transfusion; 2010 Nov; 50(11):2489-98. PubMed ID: 20529002
[TBL] [Abstract][Full Text] [Related]
18. Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.
Tran JQ; Muench MO; Jackman RP
Blood Adv; 2020 Nov; 4(21):5547-5561. PubMed ID: 33166410
[TBL] [Abstract][Full Text] [Related]
19. Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.
Saris A; Peyron I; van der Meer PF; Stuge TB; Zwaginga JJ; van Ham SM; Ten Brinke A
Front Immunol; 2018; 9():1251. PubMed ID: 29951051
[TBL] [Abstract][Full Text] [Related]
20. Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model.
Gilson CR; Zimring JC
Transfusion; 2012 Apr; 52(4):849-59. PubMed ID: 21981241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
